Decisions of Atria Plc's Annual General Meeting

Atria Plc   Company Announcement, 29 April 2021 at 14.00 pm

Decisions of Atria Plc's Annual General Meeting

Atria Plc's Annual General Meeting was held today in Helsinki at the Atria office. In order to prevent the spread of the coronavirus pandemic, the Annual General Meeting was held without shareholders’ or their proxy representatives’ presence at the venue of the meeting. A total of 88 shareholders representing 18,478,740 shares and 101,314,569 votes were represented at the meeting. The Annual General Meeting supported all the proposals made to the Annual General Meeting by at least approximately 99.34 percent of the votes cast. The General Meeting adopted the financial statements and the consolidated financial statements for the financial year of 1 January to 31 December 2020 and discharged the members of the Supervisory Board and the Board of Directors, as well as the CEO from liability for the financial period which ended on 31 December 2020.

Dividend of EUR 0.50 per share

The General Meeting resolved that a dividend of EUR 0.50 per share be distributed for the financial period which ended on 31 December 2020. Dividend is paid to a shareholder entered in the Company's shareholder register kept by Euroclear Finland Oy on the record date for the payment of the dividend. The record date is 3 May 2021 and the date of payment is 10 May 2021.

Adoption of the remuneration report of the governing bodies

The General Meeting adopted the remuneration report for the governing bodies in accordance with the proposal of the Board of Directors.

Composition and remuneration of the Supervisory Board

The General Meeting resolved that the composition of the Supervisory Board be as follows:

20 members in total

The General Meeting resolved that the remuneration of the members of the Supervisory Board be kept at the same level as in 2020. The fees are as follows: the meeting compensation is EUR 300 per meeting, the compensation for loss of working time is EUR 300 for meeting and proceeding dates, the fee of the Chairman of the Supervisory Board is EUR 1,500 a month, the fee of the Deputy Chairman is EUR 750 a month, and travelling expenses are compensated in accordance with the Company’s travel policy.

Composition and remuneration of the Board of Directors

The General Meeting resolved that the Board of Directors consist of eight (8) members. Kjell-Göran Paxal and Ahti Ritola, who were due to resign, were re-elected as members of the Board of Directors. Leena Laitinen was elected as a new member.

It was recorded that Nella Ginman-Tjeder, Jukka Kaikkonen, Pasi Korhonen, Jukka Moisio and Seppo Paavola will continue as members of the Board of Directors. Nella Ginman-Tjeder, Jukka Kaikkonen and Pasi Korhonen are due to resign from the Board of Directors at the closing of the Annual General Meeting 2022, and Seppo Paavola and Jukka Moisio are due to resign from the Board of Directors at the closing of the Annual General Meeting 2023.

The General Meeting resolved that the remuneration of the members of the Board of Directors be kept at the same level as in 2020. The fees are as follows: the meeting compensation is EUR 300 per meeting, the compensation for loss of working time is EUR 300 for meeting and proceeding dates, the fee of the Chairman of the Board of Directors is EUR 4,800 a month, the fee of the Deputy Chairman is EUR 2,600 a month, the fee of a member of the Board of Directors is EUR 2,200 a month, and travelling expenses are compensated in accordance with the Company’s travel policy.

Election and remuneration of Auditor

The General Meeting resolved, in accordance with the proposal of the Board of Directors, to elect PricewaterhouseCoopers Oy, a firm of authorised public accountants, as the Company's auditor for a term expiring at the closing of the next Annual General Meeting. The audit firm has notified that the auditor in charge is Samuli Perälä, Authorised Public Accountant. The General Meeting further resolved that the remuneration to the auditor shall be paid as per an invoice approved by the Company.

Acquisition of the Company’s own shares

The General Meeting resolved, in accordance with the proposal of the Board of Directors, to authorise the Board of Directors to resolve on the acquisition of a maximum of 2,800,000 of the Company’s own series A shares in one or more instalments with funds belonging to the Company’s unrestricted equity, subject to the provisions of the Finnish Companies Act on the maximum amount of treasury shares. The Company’s own series A shares may be acquired for use as consideration in any acquisitions or other arrangements relating to the Company’s business, to finance investments, as part of the Company’s incentive scheme, to develop the Company’s capital structure, to be otherwise further transferred, to be retained by the Company, or to be cancelled.

The shares shall be acquired in a proportion other than that of the shareholders’ current shareholdings in the Company in public trading arranged by Nasdaq Helsinki Ltd at the trading price of the moment of acquisition. The shares shall be acquired and paid according to the rules of Nasdaq Helsinki Ltd and Euroclear Finland Oy. The Board of Directors was authorised to decide on the acquisition of own shares in all other respects.

The authorisation supersedes the authorisation granted by the Annual General Meeting on 29 April 2020 to the Board of Directors to decide on the acquisition of the Company’s own shares and is valid until the closing of the next Annual General Meeting, however, no longer than until 30 June 2022.

Issuance of shares and special rights entitling to shares

The General Meeting resolved, in accordance with the proposal of the Board of Directors, to authorise the Board of Directors to resolve on an issue of a maximum total of 5,500,000 new series A shares or series A shares possibly held by the Company, in one or more instalments, by issuing shares and/or option rights or other special rights entitling to shares, referred to in Chapter 10, Section 1 of the Finnish Companies Act. The authorisation can be used for the financing or execution of any acquisitions or other arrangements or investment relating to the Company’s business, for the implementation of the Company’s incentive scheme or for other purposes subject to the Board of Directors’ decision.

The authorisation includes the Board of Directors’ right to decide on any terms and conditions of the share issue and the issue of special rights referred to in Chapter 10, Section 1 of the Finnish Companies Act. The authorisation thus also includes the right to issue shares in a proportion other than that of the shareholders’ current shareholdings in the Company under the conditions provided in law, the right to issue shares against payment or without charge as well as the right to decide on a share issue without payment to the Company itself, subject to the provisions of the Finnish Companies Act on the maximum amount of treasury shares.

The authorisation supersedes the authorisation granted by the Annual General Meeting on 29 April 2020 to the Board of Directors, and is valid until the closing of the next Annual General Meeting, however, no longer than until 30 June 2022.

Donations

The General Meeting resolved, in accordance with the proposal of the Board of Directors, to authorise the Board of Directors to donate a maximum of  EUR 100,000 of the Company’s distributable funds to support activities of colleges, universities, or other educational institutions or to support other charitable or similar purposes and at the same time authorised the Board of Directors to decide on the schedule of the payments and any other terms and conditions relating to the donations.

ATRIA PLC
Juha Gröhn
CEO

DISTRIBUTION
Nasdaq Helsinki Ltd
Major media
www.atria.com